A MULTICENTER STUDY OF ACUTE INVITRO CYTOTOXICITY IN RAT-LIVER CELLS

被引:48
作者
FAUTREL, A
CHESNE, C
GUILLOUZO, A [1 ]
DESOUSA, G
PLACIDI, M
RAHMANI, R
BRAUT, F
PICHON, J
HOELLINGER, H
VINTEZOU, P
DIARTE, I
MELCION, C
CORDIER, A
LORENZON, G
BENICOURT, M
VANNIER, B
FOURNEX, R
PELOUX, AF
BICHET, N
GOUY, D
CANO, JP
LOUNES, R
机构
[1] HOP PONTCHAILLOU,INSERM,U49,F-35033 RENNES,FRANCE
[2] RHONE POULENC RORER,INST RECH SECUR MED,F-94140 ALFORVILLE,FRANCE
[3] FAC PHARM MARSEILLE,INSERM,U278,F-13385 MARSEILLE,FRANCE
[4] INSERM,FAC MED,CNRS,UA400,F-75270 PARIS 06,FRANCE
[5] ROUSSEL ACLAF,CTR RECH GENOTOX & TERATOL,F-93239 ROMAINVILLE,FRANCE
[6] SANOFI RECH,DEPT TOXICOL,F-34802 MONTPELLIER,FRANCE
关键词
D O I
10.1016/0887-2333(91)90090-Z
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
A multicentre validation study of the acute in vitro cytotoxicity of drugs involving six French laboratories from INSERM or pharmaceutical companies has been carried out. Thirty liquid or solid chemicals such as antibiotics, anticancer drugs and solvents were selected and incubated for 20 hr with normal rat hepatocytes and FaO hepatoma cells. Miniaturized and automated methods were defined for the evaluation of cytotoxic effects. Four endpoints were evaluated: the ratio of extracellular lactate dehydrogenase to total lactate dehydrogenase, total cellular protein content, reduction of a tetrazolium salt, and neutral red uptake. For each test IC50 values were calculated. A good interlaboratory reproducibility was demonstrated. The neutral red assay was found to be the most sensitive and the least reproducible endpoint. More compounds were shown to be cytotoxic to hepatocytes than to hepatoma cells (18 v. 12). On the basis of the IC50 values a few compounds were found to be much less cytotoxic than predicted from in vivo data, suggesting that a simple experimental protocol and non-specific cytotoxicity parameters are not sufficient to test certain drug families. However, such methods appear to provide a useful means of defining the concentration range of the drug that will be selected for further analysis using more specific tests.
引用
收藏
页码:543 / 547
页数:5
相关论文
共 13 条